Mission, Vision, and Values Milestones Leadership Corporate Governance Strategic Alliances Community Outreach Information About HIV Research Focus FUZEON T-1249 Next-Generation Fusion Inhibitor Publications and Abstracts Press Releases Calendar of Events Photos and Graphics Library Stock Information Advanced Fundamentals Analyst Coverage Annual Reports SEC Filings Presentations Calendar of Events E-mail Alerts Information Request Job Postings Apply Online Employee Benefits Stock Information Advanced Fundamentals Analyst Coverage Annual Reports SEC Filings Presentations Calendar of Events E-mail Alerts Information Request FUZEON is the first in a class of anti-HIV drugs called fusion inhibitors. Learn more about the only FDA-approved fusion inhibitor... Annual Reports Receive E-mail Alerts Annual Reports | Quarterly & Other Reports Date Title Format 01/06/09 2007 Annual Report 01/30/08 2006 Annual Report 07/12/06 2005 Annual Report 08/18/05 2004 Annual Report 05/13/04 2003 Annual Report 05/14/03 2002 Annual Report 07/09/02 2001 Annual Report 08/15/01 2000 Annual Report Get help downloading or viewing the above file types ©2006 Trimeris, Inc. Site Map   |   Contact Us   |   Privacy Policy   |   Terms of Use